Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest

• Published date: 23 December 2021
• Citation: 86 FR 72995
• Record Number: 2021-27811
• Section: Notices
• Court: International Trade Commission

72995

Federal Register / Vol. 86, No. 244 / Thursday, December 23, 2021 / Notices

1

Handbook for Electronic Filing Procedures:

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf.

the Tariff Act of 1930; this notice is

published pursuant to section 207.62 of

the Commission’s rules.

By order of the Commission.

Issued: December 17, 2021.

Lisa Barton,

Secretary to the Commission.

[FR Doc. 2021–27799 Filed 12–22–21; 8:45 am]

BILLING CODE 7020–02–P

INTERNATIONAL TRADE

COMMISSION

Notice of Receipt of Complaint;

Solicitation of Comments Relating to

the Public Interest

AGENCY

: U.S. International Trade

Commission.

ACTION

: Notice.

SUMMARY

: Notice is hereby given that

the U.S. International Trade

Commission has received a complaint

entitled Certain Adalimumab, Processes

for Manufacturing or Relating to Same,

and Products Containing Same, DN

3585; the Commission is soliciting

comments on any public interest issues

raised by the complaint or

complainant’s filing pursuant to the

Commission’s Rules of Practice and

Procedure.

FOR FURTHER INFORMATION CONTACT

: Lisa

R. Barton, Secretary to the Commission,

U.S. International Trade Commission,

500 E Street SW, Washington, DC

20436, telephone (202) 205–2000. The

public version of the complaint can be

accessed on the Commission’s

Electronic Document Information

System (EDIS) at https://edis.usitc.gov.

For help accessing EDIS, please email

EDIS3Help@usitc.gov.

General information concerning the

Commission may also be obtained by

accessing its internet server at United

States International Trade Commission

(USITC) at https://www.usitc.gov. The

public record for this investigation may

be viewed on the Commission’s

Electronic Document Information

System (EDIS) at https://edis.usitc.gov.

Hearing-impaired persons are advised

that information on this matter can be

obtained by contacting the

Commission’s TDD terminal on (202)

205–1810.

SUPPLEMENTARY INFORMATION

: The

Commission has received a complaint

and a submission pursuant to § 210.8(b)

of the Commission’s Rules of Practice

and Procedure filed on behalf of AbbVie

Inc.; AbbVie Biotechnology Ltd.; and

AbbVie Operations Singapore Pte. Ltd.

on December 17, 2021. The complaint

alleges violations of section 337 of the

Tariff Act of 1930 (19 U.S.C. 1337) in

the importation into the United States,

the sale for importation, and the sale

within the United States after

importation of certain adalimumab,

processes for manufacturing or relating

to same, and products containing same.

The complainant names as respondents:

Alvotech hf. of Iceland; Alvotech

Germany GmbH of Germany; Alvotech

Swiss AG of Switzerland; Alvotech USA

Inc. of Arlington, VA; Teva

Pharmaceutical Industries Ltd. of Israel;

Teva Pharmaceuticals USA Inc. of North

Wales, PA; and Ivers-Lee AG of

Switzerland. The complainant requests

that the Commission issue a limited

exclusion order, cease and desist orders

and impose a bond upon respondents

alleged infringing articles during the 60-

day Presidential review period pursuant

to 19 U.S.C. 1337(j).

Proposed respondents, other

interested parties, and members of the

public are invited to file comments on

any public interest issues raised by the

complaint or § 210.8(b) filing.

Comments should address whether

issuance of the relief specifically

requested by the complainant in this

investigation would affect the public

health and welfare in the United States,

competitive conditions in the United

States economy, the production of like

or directly competitive articles in the

United States, or United States

consumers.

In particular, the Commission is

interested in comments that:

(i) Explain how the articles

potentially subject to the requested

remedial orders are used in the United

States;

(ii) identify any public health, safety,

or welfare concerns in the United States

relating to the requested remedial

orders;

(iii) identify like or directly

competitive articles that complainant,

its licensees, or third parties make in the

United States which could replace the

subject articles if they were to be

excluded;

(iv) indicate whether complainant,

complainant’s licensees, and/or third

party suppliers have the capacity to

replace the volume of articles

potentially subject to the requested

exclusion order and/or a cease and

desist order within a commercially

reasonable time; and

(v) explain how the requested

remedial orders would impact United

States consumers.

Written submissions on the public

interest must be filed no later than by

close of business, eight calendar days

after the date of publication of this

notice in the Federal Register. There

will be further opportunities for

comment on the public interest after the

issuance of any final initial

determination in this investigation. Any

written submissions on other issues

must also be filed by no later than the

close of business, eight calendar days

after publication of this notice in the

Federal Register. Complainant may file

replies to any written submissions no

later than three calendar days after the

date on which any initial submissions

were due. No other submissions will be

accepted, unless requested by the

Commission. Any submissions and

replies filed in response to this Notice

are limited to five (5) pages in length,

inclusive of attachments.

Persons filing written submissions

must file the original document

electronically on or before the deadlines

stated above. Submissions should refer

to the docket number (‘‘Docket No.

3585’’) in a prominent place on the

cover page and/or the first page. (See

Handbook for Electronic Filing

Procedures, Electronic Filing

Procedures).

1

Please note the Secretary’s

Office will accept only electronic filings

during this time. Filings must be made

through the Commission’s Electronic

Document Information System (EDIS,

https://edis.usitc.gov). No in-person

paper-based filings or paper copies of

any electronic filings will be accepted

until further notice. Persons with

questions regarding filing should

contact the Secretary at EDIS3Help@

usitc.gov.

Any person desiring to submit a

document to the Commission in

confidence must request confidential

treatment. All such requests should be

directed to the Secretary to the

Commission and must include a full

statement of the reasons why the

Commission should grant such

treatment. See 19 CFR 201.6. Documents

for which confidential treatment by the

Commission is properly sought will be

treated accordingly. All information,

including confidential business

information and documents for which

confidential treatment is properly

sought, submitted to the Commission for

purposes of this Investigation may be

disclosed to and used: (i) By the

Commission, its employees and Offices,

and contract personnel (a) for

developing or maintaining the records

of this or a related proceeding, or (b) in

internal investigations, audits, reviews,

and evaluations relating to the

programs, personnel, and operations of

the Commission including under 5

VerDate Sep<11>2014 20:50 Dec 22, 2021 Jkt 256001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\23DEN1.SGM 23DEN1

jspears on DSK121TN23PROD with NOTICES1

72996

Federal Register / Vol. 86, No. 244 / Thursday, December 23, 2021 / Notices

2

All contract personnel will sign appropriate

nondisclosure agreements.

3

Electronic Document Information System

(EDIS): https://edis.usitc.gov.

U.S.C. Appendix 3; or (ii) by U.S.

government employees and contract

personnel,

2

solely for cybersecurity

purposes. All nonconfidential written

submissions will be available for public

inspection at the Office of the Secretary

and on EDIS.

3

This action is taken under the

authority of section 337 of the Tariff Act

of 1930, as amended (19 U.S.C. 1337),

and of §§ 201.10 and 210.8(c) of the

Commission’s Rules of Practice and

Procedure (19 CFR 201.10, 210.8(c)).

By order of the Commission.

Issued: December 17, 2021.

Lisa Barton,

Secretary to the Commission.

[FR Doc. 2021–27811 Filed 12–22–21; 8:45 am]

BILLING CODE 7020–02–P

DEPARTMENT OF JUSTICE

Bureau of Alcohol, Tobacco, Firearms,

and Explosives

[Docket No. 2021R–01]

Commerce in Explosives; 2021 Annual

List of Explosive Materials

AGENCY

: Bureau of Alcohol, Tobacco,

Firearms, and Explosives (ATF),

Department of Justice.

ACTION

: Notice of list of explosive

materials.

SUMMARY

: This notice publishes the

2021 List of Explosive Materials, as

required by law. The 2021 list is the

same as the 2020 list published by ATF.

DATES

: The list becomes effective

December 23, 2021.

FOR FURTHER INFORMATION CONTACT

:

Marianna Mitchem, Chief; Firearms and

Explosives Industry Division; Bureau of

Alcohol, Tobacco, Firearms, and

Explosives; United States Department of

Justice; 99 New York Avenue NE,

Washington, DC 20226; (202) 648–7120.

SUPPLEMENTARY INFORMATION

: Pursuant

to 18 U.S.C. 841(d) and 27 CFR 555.23,

the Department of Justice must publish

and revise at least annually in the

Federal Register a list of explosives

determined to be within the coverage of

18 U.S.C. 841 et seq. The list covers not

only explosives, but also blasting agents

and detonators, all of which are defined

as ‘‘explosive materials’’ in 18 U.S.C.

841(c).

Each material listed, as well as all

mixtures containing any of these

materials, constitute ‘‘explosive

materials’’ under 18 U.S.C. 841(c).

Materials constituting blasting agents

are marked by an asterisk. Explosive

materials are listed alphabetically, and,

where applicable, followed by their

common names, chemical names, and/

or synonyms in brackets. This list

supersedes the List of Explosive

Materials published in the Federal

Register on December 23, 2020 (Docket

No. 2020R–01, 85 FR 83999).

The 2021 List of Explosive Materials

is a comprehensive list, but is not all-

inclusive. The definition of ‘‘explosive

materials’’ includes ‘‘[e]xplosives,

blasting agents, water gels and

detonators. Explosive materials,

include, but are not limited to, all items

in the ‘List of Explosive Materials’

provided for in § 555.23.’’ 27 CFR

555.11. Accordingly, the fact that an

explosive material is not on the annual

list does not mean that it is not within

coverage of the law if it otherwise meets

the statutory definition of ‘‘explosives’’

in 18 U.S.C. 841. Subject to limited

exceptions in 18 U.S.C. 845 and 27 CFR

555.141, only Federal explosives

licensees and permittees may possess

and use explosive materials, including

those on the annual list.

Notice of the 2021 Annual List of

Explosive Materials

Pursuant to 18 U.S.C. 841(d) and 27

CFR 555.23, I hereby designate the

following as ‘‘explosive materials’’

covered under 18 U.S.C. 841(c):

A

Acetylides of heavy metals.

Aluminum containing polymeric

propellant.

Aluminum ophorite explosive.

Amatex.

Amatol.

Ammonal.

Ammonium nitrate explosive mixtures

(cap sensitive).

* Ammonium nitrate explosive mixtures

(non-cap sensitive).

Ammonium perchlorate having particle

size less than 15 microns.

Ammonium perchlorate explosive

mixtures (excluding ammonium perchlorate

composite propellant (APCP)).

Ammonium picrate [picrate of ammonia,

Explosive D].

Ammonium salt lattice with

isomorphously substituted inorganic salts.

* ANFO [ammonium nitrate-fuel oil].

Aromatic nitro-compound explosive

mixtures.

Azide explosives.

B

Baranol.

Baratol.

BEAF [1, 2-bis (2, 2-difluoro-2-

nitroacetoxyethane)].

Black powder.

Black powder based explosive mixtures.

Black powder substitutes.

* Blasting agents, nitro-carbo-nitrates,

including non-cap sensitive slurry and water

gel explosives.

Blasting caps.

Blasting gelatin.

Blasting powder.

BTNEC [bis (trinitroethyl) carbonate].

BTNEN [bis (trinitroethyl) nitramine].

BTTN [1,2,4 butanetriol trinitrate].

Bulk salutes.

Butyl tetryl.

C

Calcium nitrate explosive mixture.

Cellulose hexanitrate explosive mixture.

Chlorate explosive mixtures.

Composition A and variations.

Composition B and variations.

Composition C and variations.

Copper acetylide.

Cyanuric triazide.

Cyclonite [RDX].

Cyclotetramethylenetetranitramine [HMX].

Cyclotol.

Cyclotrimethylenetrinitramine [RDX].

D

DATB [diaminotrinitrobenzene].

DDNP [diazodinitrophenol].

DEGDN [diethyleneglycol dinitrate].

Detonating cord.

Detonators.

Dimethylol dimethyl methane dinitrate

composition.

Dinitroethyleneurea.

Dinitroglycerine [glycerol dinitrate].

Dinitrophenol.

Dinitrophenolates.

Dinitrophenyl hydrazine.

Dinitroresorcinol.

Dinitrotoluene-sodium nitrate explosive

mixtures.

DIPAM [dipicramide;

diaminohexanitrobiphenyl].

Dipicryl sulfide [hexanitrodiphenyl

sulfide].

Dipicryl sulfone.

Dipicrylamine.

Display fireworks.

DNPA [2,2-dinitropropyl acrylate].

DNPD [dinitropentano nitrile].

Dynamite.

E

EDDN [ethylene diamine dinitrate].

EDNA [ethylenedinitramine].

Ednatol.

EDNP [ethyl 4,4-dinitropentanoate].

EGDN [ethylene glycol dinitrate].

Erythritol tetranitrate explosives.

Esters of nitro-substituted alcohols.

Ethyl-tetryl.

Explosive conitrates.

Explosive gelatins.

Explosive liquids.

Explosive mixtures containing oxygen-

releasing inorganic salts and hydrocarbons.

Explosive mixtures containing oxygen-

releasing inorganic salts and nitro bodies.

Explosive mixtures containing oxygen-

releasing inorganic salts and water insoluble

fuels.

Explosive mixtures containing oxygen-

releasing inorganic salts and water soluble

fuels.

VerDate Sep<11>2014 20:50 Dec 22, 2021 Jkt 256001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 E:\FR\FM\23DEN1.SGM 23DEN1

jspears on DSK121TN23PROD with NOTICES1